Merck
George Merck-founded pharmaceutical company Merck has found a serious backer in Warren Buffett because, during the third quarter of 2020, his Berkshire Hathaway bought 22.4 million shares. Another firm, SRB Corp., has been putting money in this New Jersey-based company.
The hedge fund has been sticking with Merck since 2011 and had purchased shares in the third quarter of 2020. Merck makes for SRB Corp.’s 13 percent of holdings, or 1.7 percent higher than its previous position. One of Merck’s greatest stockholder magnets is its promising drug for cancer called Keytruda.
